Your session is about to expire
← Back to Search
LY3857210 for Osteoarthritis (OA05 Trial)
OA05 Trial Summary
This trial tests a new drug to see if it relieves pain in those with osteoarthritis.
- Osteoarthritis of the Knee
OA05 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOA05 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OA05 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many healthcare facilities have been approved to carry out this experiment?
"The trial is being operated in 28 different locations, such as Arizona Research Center based in Phoenix, Suncoast Research Group located near Miami, and Synexus Clinical Research US Inc. situated in Chandler."
Are there vacancies in this clinical venture for participants?
"Clinicaltrials.gov reveals that, as of November 11th 2022, this particular medical trial is no longer accepting applications from prospective participants. The original post date was 22nd November 2022. However, 1084 trials are still actively recruiting individuals at this time."
Has the FDA sanctioned LY3857210 for usage?
"With clinical evidence backing its safety, our experts at Power rated LY3857210 with a score of 2 given that this is still a Phase 2 trial, which means there's no data yet to support efficacy."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger